The HIF1 target gene NOX2 promotes angiogenesis through urotensin-II

Journal of Cell Science

Volumn 125, Issue 4, 2012, Pages 956-964

  Diebold, Isabel ^a   Petry, Andreas ^a   Sabrane, Karim ^a   Djordjevic, Talija ^a   Hess, John ^a   Görlach, Agnes ^a,b  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Munich Heart Alliance   (Germany)

Author keywords

Angiogenesis; Endothelial; HIF 1; NADPH oxidase; NOX2; Reactive oxygen species; Urotensin II

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; UROTENSIN II;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; CELL HYPOXIA; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; UPREGULATION;

ANIMALS; FEEDBACK, PHYSIOLOGICAL; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1; MEMBRANE GLYCOPROTEINS; MICE; NADPH OXIDASE; NEOVASCULARIZATION, PATHOLOGIC; NEOVASCULARIZATION, PHYSIOLOGIC; REACTIVE OXYGEN SPECIES; RECEPTORS, G-PROTEIN-COUPLED; RNA, MESSENGER; UP-REGULATION; UROTENSINS;

MUS;

EID: 84861207869     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.094060     Document Type: Article

References (37)

1. Ames, R. S., Sarau, H. M., Chambers, J. K., Willette, R. N., Aiyar, N. V., Romanic, A. M., Louden, C. S., Foley, J. J., Sauermelch, C. F., Coatney, R. W. et al. (1999). Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401, 282-286
2. BelAiba, R. S., Djordjevic, T., Bonello, S., Flugel, D., Hess, J., Kietzmann, T. and Gorlach, A. (2004). Redox-sensitive regulation of the HIF pathway under nonhypoxic conditions in pulmonary artery smooth muscle cells. Biol. Chem. 385, 249-257.
3. BelAiba, R. S., Djordjevic, T., Petry, A., Diemer, K., Bonello, S., Banfi, B., Hess, J., Pogrebniak, A., Bickel, C. and Gorlach, A. (2007). NOX5 variants are functionally active in endothelial cells. Free Radic. Biol. Med. 42, 446-459
4. Bonello, S., Zahringer, C., BelAiba, R. S., Djordjevic, T., Hess, J., Michiels, C., Kietzmann, T. and Gorlach, A. (2007). Reactive oxygen species activate the HIF-1alpha promoter via a functional NFkappaB site. Arterioscler. Thromb. Vasc. Biol. 27, 755-761.
5. Coulon, C., Georgiadou, M., Roncal, C., De Bock, K., Langenberg, T. and Carmeliet, P. (2010). From vessel sprouting to normalization: role of the prolyl hydroxylase domain protein/hypoxia-inducible factor oxygen-sensing machinery. Arterioscler. Thromb. Vasc. Biol. 30, 2331-2336.
6. del Peso, L., Castellanos, M. C., Temes, E., Martin-Puig, S., Cuevas, Y., Olmos, G. and Landazuri, M. O. (2003). The von Hippel Lindau/hypoxia-inducible factor (HIF) pathway regulates the transcription of the HIF-proline hydroxylase genes in response to low oxygen. J. Biol. Chem. 278, 48690-48695.
7. Dery, M. A., Michaud, M. D. and Richard, D. E. (2005). Hypoxia-inducible factor 1: regulation by hypoxic and non-hypoxic activators. Int. J. Biochem. Cell Biol. 37, 535-540.
8. Diebold, I., Djordjevic, T., Petry, A., Hatzelmann, A., Tenor, H., Hess, J. and Gorlach, A. (2009). Phosphodiesterase 2 mediates redox-sensitive endothelial cell proliferation and angiogenesis by thrombin via Rac1 and NADPH oxidase 2. Circ. Res. 104, 1169-1177.
9. Diebold, I., Petry, A., Hess, J. and Gorlach, A. (2010a). The NADPH oxidase subunit NOX4 is a new target gene of the hypoxia-inducible factor-1. Mol. Biol. Cell 21, 2087-2096.
10. Diebold, I., Flugel, D., Becht, S., Belaiba, R. S., Bonello, S., Hess, J., ietzmann, T. and Gorlach, A. (2010b). The hypoxia-inducible factor-2alpha is stabilized by oxidative stress involving NOX4. Antioxid. Redox Signal. 13, 425-436.
11. Diebold, I., Petry, A., Djordjevic, T., Belaiba, R. S., Fineman, J., Black, S., Schreiber, C., Fratz, S., Hess, J., Kietzmann, T. et al. (2010c). Reciprocal regulation of Rac1 and PAK-1 by HIF-1alpha: a positive-feedback loop promoting pulmonary vascular remodeling. Antioxid. Redox Signal. 13, 399-412.
12. Djordjevic, T. and Gorlach, A. (2007). Urotensin-II in the lung: a matter for vascular remodelling and pulmonary hypertension? Thromb. Haemost. 98, 952-962.
13. Djordjevic, T., BelAiba, R. S., Bonello, S., Pfeilschifter, J., Hess, J. and Gorlach, A.(2005). Human urotensin II is a novel activator of NADPH oxidase in human pulmonary artery smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 25, 519-525.
14. El-Benna, J., Dang, P. M. and Gougerot-Pocidalo, M. A. (2008). Priming of the neutrophil NADPH oxidase activation: role of p47phox phosphorylation and NOX2 mobilization to the plasma membrane. Semin. Immunopathol. 30, 279-289.
15. Folkman, J. (2003). Fundamental concepts of the angiogenic process. Curr. Mol. Med. 3, 643-651
16. Gorlach, A. and Kietzmann, T. (2007). Superoxide and derived reactive oxygen species in the regulation of hypoxia-inducible factors. Methods Enzymol. 435, 421-446.
17. Gorlach, A., Brandes, R. P., Nguyen, K., Amidi, M., Dehghani, F. and Busse, R. (2000). A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ. Res. 87, 26-32.
18. Gorlach, A., Diebold, I., Schini-Kerth, V. B., Berchner-Pfannschmidt, U., Roth, U., Brandes, R. P., Kietzmann, T. and Busse, R. (2001). Thrombin activates the hypoxia-inducible factor-1 signaling pathway in vascular smooth muscle cells: Role of the p22(phox)-containing NADPH oxidase. Circ. Res. 89, 47-54
19. Kietzmann, T., Knabe, W. and Schmidt-Kastner, R. (2001). Hypoxia and hypoxiainducible factor modulated gene expression in brain: involvement in neuroprotection and cell death. Eur. Arch. Psychiatry Clin. Neurosci. 251, 170-178.
20. Klein, A., Flugel, D. and Kietzmann, T. (2008). Transcriptional regulation of serine/threonine kinase-15 (STK15) expression by hypoxia and HIF-1. Mol. Biol. Cell 19, 3667-3675.
21. Lassegue, B. and Griendling, K. K. (2010). NADPH oxidases: functions and pathologies in the vasculature. Arterioscler. Thromb. Vasc. Biol. 30, 653-661.
22. Maguire, J. J. and Davenport, A. P. (2002). Is urotensin-II the new endothelin? Br. J. Pharmacol. 137, 579-588.
23. Maulik, N. (2002). Redox signaling of angiogenesis. Antioxid. Redox Signal. 4, 805-815.
24. Petry, A., Djordjevic, T., Weitnauer, M., Kietzmann, T., Hess, J. and Gorlach, A. (2006). NOX2 and NOX4 mediate proliferative response in endothelial cells.Antioxid. Redox Signal. 8, 1473-1484.
25. Pollock, J. D., Williams, D. A., Gifford, M. A., Li, L. L., Du, X., Fisherman, J., Orkin, S. H., Doerschuk, C. M. and Dinauer, M. C. (1995). Mouse model of Xlinked chronic granulomatous disease, an inherited defect in phagocyte superoxide production. Nat. Genet. 9, 202-209.
26. Ratcliffe, P. J., O'Rourke, J. F., Maxwell, P. H. and Pugh, C. W. (1998). Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J. Exp. Biol. 201, 1153-1162.
27. Ribatti, D., Conconi, M. T. and Nussdorfer, G. G. (2007). Nonclassic endogenous novel [corrected] regulators of angiogenesis. Pharmacol. Rev. 59, 185-205.
28. Ryan, H. E., Poloni, M., McNulty, W., Elson, D., Gassmann, M., Arbeit, J. M. and Johnson, R. S. (2000). Hypoxia-inducible factor-1alpha is a positive factor in solid tumor growth. Cancer Res. 60, 4010-4015.
29. Semenza, G. L. (2000). HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88, 1474-1480.
30. Semenza, G. L. (2001). HIF-1, O(2), and the 3 PHDs: how animal cells signal hypoxia to the nucleus. Cell 107, 1-3.
31. Spinazzi, R., Albertin, G., Nico, B., Guidolin, D., Di Liddo, R., Rossi, G. P., Ribatti, D. and Nussdorfer, G. G. (2006). Urotensin-II and its receptor (UT-R) are expressed in rat brain endothelial cells, and urotensin-II via UT-R stimulates angiogenesis in vivo and in vitro. Int. J. Mol. Med. 18, 1107-1112.
32. Takahashi, K., Totsune, K., Murakami, O., Arihara, Z., Noshiro, T., Hayashi, Y. and Shibahara, S. (2003). Expression of urotensin II and its receptor in adrenal tumors and stimulation of proliferation of cultured tumor cells by urotensin II. Peptides 24, 301-306.
33. Tojo, T., Ushio-Fukai, M., Yamaoka-Tojo, M., Ikeda, S., Patrushev, N. and Alexander, R. W. (2005). Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia. Circulation 111, 2347-2355.
34. Ushio-Fukai, M., Tang, Y., Fukai, T., Dikalov, S. I., Ma, Y., Fujimoto, M., Quinn, M. T., Pagano, P. J., Johnson, C. and Alexander, R. W. (2002). Novel role of gp91(phox)-containing NAD(P)H oxidase in vascular endothelial growth factorinduced signaling and angiogenesis. Circ. Res. 91, 1160-1167.
35. Watanabe, T., Arita, S., Shiraishi, Y., Suguro, T., Sakai, T., Hongo, S. and Miyazaki, A. (2009). Human urotensin II promotes hypertension and atherosclerotic cardiovascular diseases. Curr. Med. Chem. 16, 550-563
36. Wenger, R. H., Stiehl, D. P. and Camenisch, G. (2005). Integration of oxygen signaling at the consensus HRE. Sci. STKE
37. Yoshimoto, T., Matsushita, M. and Hirata, Y. (2004). Role of urotensin II in peripheral tissue as an autocrine/paracrine growth factor. Peptides 25, 1775-1781